Biblio Discovery — Demo Discovery Service

18 results

Showing 1–18 · 0.71 seconds · RSS

Journal

British Journal of Pharmacology

Scopus

ISSN 0007-1188 · Wiley · 18 articles in the index

  1. Journal Article Full text

    Guidance on the planning and reporting of experimental design and analysis

    Michael J. Curtis; S P H Alexander; Miriam Margherita Cortese-Krott et al.

    British Journal of Pharmacology · 2025 · English · OpenAlex Scopus

    The aim of this guidance document is to help authors plan experiments, conduct analyses and present the results of work intended for publication in the British Journal of Pharmacology (BJP).The guidance is structured to minimize the risk of generating and publishing false findings.Below, we explain…

  2. Journal Article Full text

    Transcriptome‐level discovery of survival‐associated biomarkers and therapy targets in non‐small‐cell lung cancer

    Balázs Győrffy

    British Journal of Pharmacology · 2023 · English · OpenAlex Scopus

    BACKGROUND AND PURPOSE: Survival rate of patients with lung cancer has increased by over 60% in the recent two decades. With longer survival, the identification of genes associated with survival has emerged as an issue of utmost importance to uncover the most promising biomarkers and therapeutic…

  3. Journal Article Full text

    The Concise Guide to PHARMACOLOGY 2023/24: Enzymes

    S P H Alexander; Doriano Fabbro; Eamonn P. Kelly et al.

    British Journal of Pharmacology · 2023 · English · OpenAlex Scopus

    The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands. There is an emphasis…

  4. Journal Article Full text

    The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors

    S P H Alexander; Arthur Christopoulos; Anthony P. Davenport et al.

    British Journal of Pharmacology · 2023 · English · OpenAlex Scopus

    The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands. There is an emphasis…

  5. Journal Article Full text

    Community guidelines for GPCR ligand bias: IUPHAR review 32

    Peter Kolb; Terry Kenakin; S P H Alexander et al.

    British Journal of Pharmacology · 2022 · English · OpenAlex Scopus

    GPCRs modulate a plethora of physiological processes and mediate the effects of one-third of FDA-approved drugs. Depending on which ligand activates a receptor, it can engage different intracellular transducers. This 'biased signalling' paradigm requires that we now characterize physiological…

  6. Journal Article Full text

    THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

    S P H Alexander; Arthur Christopoulos; Anthony P. Davenport et al.

    British Journal of Pharmacology · 2021 · English · OpenAlex Scopus

    The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to…

  7. Journal Article Full text

    THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

    S P H Alexander; Doriano Fabbro; Eamonn P. Kelly et al.

    British Journal of Pharmacology · 2021 · English · OpenAlex Scopus

    The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to…

  8. Journal Article Full text

    THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets

    S P H Alexander; Eamonn P. Kelly; Alistair A. Mathie et al.

    British Journal of Pharmacology · 2021 · English · OpenAlex Scopus

    The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to…

  9. Journal Article Full text

    The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders

    Mette Kruse Klausen; Morgane Thomsen; Gitta Wörtwein et al.

    British Journal of Pharmacology · 2021 · English · OpenAlex Scopus

    Drug, alcohol and tobacco use disorders are a global burden affecting millions of people. Despite decades of research, treatment options are sparse or missing, and relapse rates are high. Glucagon-like peptide 1 (GLP-1) is released in the small intestine, promotes blood glucose homeostasis, slows…

  10. Journal Article Full text

    Osteosarcoma mechanobiology and therapeutic targets

    Zunaira Shoaib; Timothy M. Fan; Joseph Irudayaraj

    British Journal of Pharmacology · 2021 · English · OpenAlex Scopus

    Osteosarcoma is one of the most common primary tumours of the bone, with a 5-year survival rate of less than 20% after the development of metastases. Osteosarcoma is highly predisposed in Paget's disease of the bone, and both have common characteristic skeletal features due to rapid bone…

  11. Journal Article Full text

    THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels

    S P H Alexander; Alistair A. Mathie; John A. Peters et al.

    British Journal of Pharmacology · 2021 · English · OpenAlex Scopus

    The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to…

  12. Journal Article Full text

    Current pharmacological treatments for COVID‐19: What's next?

    Cristina Scavone; Simona Brusco; Michele Bertini et al.

    British Journal of Pharmacology · 2020 · English · OpenAlex Scopus

    Since December 2019 SARS-Cov-2 was found responsible for the disease COVID-19, which has spread worldwide. No specific therapies/vaccines are yet available for the treatment of COVID-19. Drug repositioning may offer a strategy and a number of drugs have been repurposed, including…

  13. Journal Article Full text

    Update of P2X receptor properties and their pharmacology: IUPHAR Review 30

    Péter Illés; Christa Elisabeth Müller; Kenneth A. Jacobson et al.

    British Journal of Pharmacology · 2020 · English · OpenAlex Scopus

    The known seven mammalian receptor subunits (P2X1-7) form cationic channels gated by ATP. Three subunits compose a receptor channel. Each subunit is a polypeptide consisting of two transmembrane regions (TM1 and TM2), intracellular N- and C-termini, and a bulky extracellular loop. Crystallization…

  14. Journal Article

    Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF‐κB and TNF‐α/TNFR1/NF‐κB pathways

    Xiang Ming Xu; Hu‐Nan Piao; Fumie Aosai et al.

    British Journal of Pharmacology · 2020 · English · OpenAlex Scopus

    BACKGROUND AND PURPOSE: Arctigenin, a major bioactive component of Fructus arctii, has been reported to have antidepressant-like effects. However, the mechanisms underlying these effects are still unclear. Neuroinflammation can be caused by excessive production of proinflammatory cytokines in…

  15. Journal Article

    ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

    Elliot J. Lilley; S. Clare Stanford; David E. Kendall et al.

    British Journal of Pharmacology · 2020 · English · OpenAlex Scopus

    The BJP has been and remains an active advocate of the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines (Kilkenny, Browne, Cuthill, Emerson, & Altman, 2010a) that were established by the National Centre for the Replacement, Refinement and Reduction of Animals in Research…

  16. Journal Article Full text

    The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

    Nathalie Percie du Sert; Viki Hurst; Amrita Ahluwalia et al.

    British Journal of Pharmacology · 2020 · English · OpenAlex Scopus

    Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of a checklist of information to include in publications describing in vivo…

  17. Journal Article Full text

    Morphine‐induced respiratory depression is independent of β‐arrestin2 signalling

    Andrea Kliewer; Alexander Gillis; Rob Hill et al.

    British Journal of Pharmacology · 2020 · English · OpenAlex Scopus

    BACKGROUND AND PURPOSE: GPCRs can signal through both G proteins and β-arrestin2. For the μ-opioid receptor, early experimental evidence from a single study suggested that G protein signalling mediates analgesia, whereas β-arrestin2 signalling mediates respiratory depression and constipation…

  18. Journal Article Full text

    Update of P2Y receptor pharmacology: IUPHAR Review 27

    Kenneth A. Jacobson; Esmerilda G. Delicado; Christian G. Gachet et al.

    British Journal of Pharmacology · 2020 · English · OpenAlex Scopus

    Eight G protein‐coupled P2Y receptor subtypes respond to extracellular adenine and uracil mononucleotides and dinucleotides. P2Y receptors belong to the δ group of rhodopsin‐like GPCRs and contain two structurally distinct subfamilies: P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , and P2Y 11 (principally G q…